Home/Filings/4/0001567619-22-012379
4//SEC Filing

Rice William G. 4

Accession 0001567619-22-012379

CIK 0000882361other

Filed

Jun 5, 8:00 PM ET

Accepted

Jun 6, 4:13 PM ET

Size

5.5 KB

Accession

0001567619-22-012379

Insider Transaction Report

Form 4
Period: 2022-06-06
Rice William G.
DirectorChair, President & CEO
Transactions
  • Purchase

    Common Shares

    2022-06-06$0.97/sh+10,000$9,681353,252 total
Footnotes (1)
  • [F1]The purchase price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9651 to $0.9702, inclusive. The reporting person undertakes to provide to Aptose Biosciences Inc., any security holder of Aptose Biosciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Documents

1 file

Issuer

Aptose Biosciences Inc.

CIK 0000882361

Entity typeother

Related Parties

1
  • filerCIK 0001761487

Filing Metadata

Form type
4
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 4:13 PM ET
Size
5.5 KB